|
Rochester NY, 16 February 17, 2024 – RESILIÉLLETM Cosmetics LLC, a leader in innovative skincare and haircare solutions, proudly welcomes to the company Dr. Carla Mazzeo PhD, a global authority in exosome research who has more than 30 publications. She will spearhead company advancements in exosome-based skin, scalp, and hair care. Dr. Mazzeo, a leader in exosome research since 2004, was a Director and Senior Scientific Researcher at Boston University and Boston University Medical Center. She brings unparalleled expertise to enhance RESILIÉLLE’s commitment to excellence.
Dr. Mazzeo says she was attracted to RESILIÉLLE Cosmetics LLC because the company is pioneering cutting-edge skincare and haircare solutions using Age Zero Exosomes and is committed to redefining beauty standards through innovation and scientific excellence.
RESILIÉLLE manufactures the world’s largest production of Age Zero Exosomes in an ISO 7 Cleanroom using “low passage” stem cell expansion standards. In that way, the RESILIÉLLE Exosomes maintain their original characteristics and potency. In order to ensure the integrity of their product’s exosome membrane, for example, Age Zero RESILIÉLLE Exosome products are frozen but are never freeze-dried during manufacture, in contrast to other exosome products sold on the beauty market. This manufacturing process results in the unmatched quality and efficacy of RESILIÉLLE skincare formulations. Furthermore, the product is independently tested by a US certified CLIA laboratory. Consequently, customers can have confidence in the integrity and safety of Age Zero RESILIÉLLE Exosomes.
RESILIÉLLE CEO Erin Crowley emphasizes the importance of customers being able to distinguish true exosome products from imitations currently flooding the market. “We refuse to compromise on quality, testing, or manufacturing standards. Dr. Mazzeo’s unique ability to fully characterize exosomes sets us apart and allows us to expose subpar products. Our dedication to Age Zero ‘low passage’ certified manufacturing standards positions RESILIÉLLE as the leading exosome firm.”
Dr. Mazzeo asserts, “In the dynamic realm of exosomes, RESILIÉLLE stands unrivaled as the global standard bearer, defining Age Zero Certified excellence. Meticulously researched, our exosomes come from Wharton’s jelly-derived MSCs (Mesenchymal Stem Cells), the gold standard for stem cells. That elevates RESILIÉLLE to manufacturing the pinnacle of product quality. Because they are independently tested by US Certified CLIA labs, our product ships with a certified guarantee. If your current provider lacks this commitment to safety and quality, it’s time to question their legitimacy.”
RESILIÉLLE CEO Erin Crowley notes: “I am a quality engineer and Lead ISO Auditor. Quality reigns supreme as our company’s ethos. Transparency is our mantra, and we invite you to witness our production firsthand. We set the gold standard for exosome quality, and we’re on a mission to expose the fake exosome products in the skincare world.”
Crowley explains, “We’re setting new standards in skincare, driven by scientific validation. Our recent 100-participant trial of the use of our exosome products with microneedling is a game-changer. The results demonstrated that our Age Zero Exosomes are the future of effective skincare.”
To learn more about the trial results, click here https://vimeo.com/showcase/10915325
About RESILIÉLLE Cosmetics LLC
RESILIÉLLE Cosmetics LLC pioneers cutting-edge skincare and haircare solutions, committed to redefining beauty standards through innovation and scientific excellence.
RESILIÉLLE guarantees the authenticity and purity of their products, that means, no freeze-drying, no imitations, just pure, low passage, Age-Zero Exosomes that customers can count on to lead to their having radiant, youthful skin and lustrous hair.
Serving an increasing number of global markets, RESILIÉLLE has forged exclusive distribution deals in the United Arab Emirates with reputable partners, such as Great Look Medical Inc., as well as Joy Med in Lebanon, and Arab Health Care in Kuwait. This strategic expansion underscores recognition of RESILIÉLLE’s commitment to exosome excellence.
RESILIÉLLE is a wholly owned subsidiary of The Crowley Center for Regenerative & Biotherapeutics, funded, commercialized, and launched by Rochester, NY-based AT Venture Center, a majority women-owned and operated firm AT Venture Center.
For more information, please visit RESILIÉLLE, in the UAE, Great Look Medical Inc., in Lebanon, Joy Med, or in Kuwait, Arab Health Care.
Tell Us What You Think!